Sabby Management’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Sabby Management’s Portfolio WGBS Stock Details WGBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-358,535	Closed	-$1.77M	–	365
2016 Q4	$1.77M	Buy	358,535 +42,812	+14%	+$188K	0.1%	111
2016 Q3	$1.52M	Sell	315,723 -57,727	-15%	-$259K	0.06%	152
2016 Q2	$1.53M	Buy	373,450 +134,356	+56%	+$501K	0.08%	128
2016 Q1	$765K	Sell	239,094 -37,121	-13%	-$119K	0.04%	178
2015 Q4	$1.01M	Buy	+276,215	New	+$1.37M	0.06%	178
2015 Q1	–	Sell	-117,051	Closed	-$1.76K	–	340
2014 Q4	$1.76K	Buy	117,051 +5,731	+5%	+$107K	0.06%	135
2014 Q3	$2.42K	Buy	+111,320	New	+$2.48M	0.09%	97

Sabby Management's WGBS Position: Q1 2017 in Review

Sabby Management sold out of WaferGen Bio-systems, Inc. (WGBS) in Q1 2017, closing a stake of 358,535 shares — an estimated $1.77M sold.

Sabby Management first reported a position in WGBS in Q3 2014 and held it in 7 quarters. The position peaked at $1.77M in Q4 2016. 0 funds tracked by Wall St. Rank hold WGBS as of Q1 2017.

Sabby Management reported no remaining WaferGen Bio-systems, Inc. position as of Q1 2017 after selling out during the quarter.
Sabby Management sold 358,535 WaferGen Bio-systems, Inc. shares in Q1 2017, an estimated $1.77M.
Sabby Management first reported a position in WaferGen Bio-systems, Inc. in Q3 2014 and held it in 7 quarters.
Sabby Management's WaferGen Bio-systems, Inc. position peaked at $1.77M in Q4 2016.
0 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.